“你能做的任何事，我都能做得更厉害？”：关于身材正常的矮小儿童使用生长激素的伦理与公平性问题
"Anything you can do, I can do bigger?": the ethics and equity of growth hormone for small normal children.
作者信息
Gill D G
机构信息
Department of Paediatrics RCSI, Children's University Hospital, Temple Street, Dublin 1, Ireland.
出版信息
Arch Dis Child. 2006 Mar;91(3):270-2. doi: 10.1136/adc.2005.081778.
Abstract
This paper argues against the use of growth hormone (GH) for small normal children ("idiopathic" short stature) with the following considerations: ethical (philosophical) grounds, cost-economic implications, and the rationale for treating normal physiological variation with a potent pharmacological agent. The author would prefer to see health and economic resources being directed to correct nutritional and environmental deprivation among underprivileged groups in preference to providing GH injections for small normal children.
摘要
本文基于以下几点考虑，反对给正常身材矮小的儿童（“特发性”身材矮小）使用生长激素（GH）：伦理（哲学）依据、成本-经济影响，以及使用强效药物治疗正常生理变异的基本原理。作者更希望看到健康和经济资源用于纠正弱势群体中存在的营养和环境匮乏问题，而不是给正常身材矮小的儿童注射生长激素。
相似文献
1
"Anything you can do, I can do bigger?": the ethics and equity of growth hormone for small normal children.“你能做的任何事，我都能做得更厉害？”：关于身材正常的矮小儿童使用生长激素的伦理与公平性问题
Arch Dis Child. 2006 Mar;91(3):270-2. doi: 10.1136/adc.2005.081778.
2
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).特发性生长激素缺乏症、特纳综合征或特发性身材矮小的青春期前儿童，以及小于胎龄儿出生的矮小儿童在生长激素治疗第一年的骨龄进展：来自辉瑞国际生长数据库（KIGS）的数据分析
Horm Res. 2005;63(1):40-7. doi: 10.1159/000082872. Epub 2004 Dec 22.
3
Growth hormone use in children: necessary or designer therapy?儿童生长激素治疗：必要还是设计疗法？
J Pediatr Health Care. 2011 Jan-Feb;25(1):24-30. doi: 10.1016/j.pedhc.2010.03.005. Epub 2010 Apr 27.
4
Developments in idiopathic short stature: cost versus allocation of resources.特发性身材矮小的发展：成本与资源分配。
Horm Res Paediatr. 2011;76 Suppl 3:33-5. doi: 10.1159/000330153. Epub 2011 Sep 7.
5
Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.生长激素治疗胎龄小的身材矮小儿童的成本效益。
Clin Ther. 2010 Jun;32(6):1068-82. doi: 10.1016/j.clinthera.2010.05.012.
6
Growth hormone treatment for short stature in children born small for gestational age.生长激素治疗小于胎龄儿儿童身材矮小症。
Adv Ther. 2008 Oct;25(10):951-78. doi: 10.1007/s12325-008-0101-3.
7
Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.关于小于胎龄出生的青春期前矮小儿童在大剂量生长激素治疗前及治疗期间对身高、外貌和心理社会功能的担忧、期望及认知。
Horm Res. 2008;69(6):334-42. doi: 10.1159/000117389. Epub 2008 Mar 17.
8
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.生长激素治疗与青春期对特发性身材矮小和生长激素缺乏症儿童骨骼及身体成分的影响。
Bone. 2005 Nov;37(5):642-50. doi: 10.1016/j.bone.2005.06.012. Epub 2005 Sep 1.
9
Physiological assessment of growth hormone secretion in the diagnosis of children with short stature.生长激素分泌的生理评估在矮小儿童诊断中的应用
Pediatrician. 1987;14(3):121-37.
10
GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.生长激素治疗及其对小于胎龄儿出生的矮小儿童骨密度、骨成熟和生长的影响：一项随机对照生长激素试验的3年结果
Clin Endocrinol (Oxf). 2003 Dec;59(6):779-87. doi: 10.1046/j.1365-2265.2003.01905.x.
引用本文的文献
1
Medicalising short children with growth hormone? Ethical considerations of the underlying sociocultural aspects.用生长激素治疗身材矮小的儿童？潜在社会文化因素的伦理考量。
Med Health Care Philos. 2018 Jun;21(2):243-253. doi: 10.1007/s11019-017-9798-6.
2
Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee.回应成年患者对神经增强药物的需求：伦理、法律与人文委员会的指导意见
Neurology. 2009 Oct 27;73(17):1406-12. doi: 10.1212/WNL.0b013e3181beecfe. Epub 2009 Sep 23.
本文引用的文献
1
Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect.生长激素（GH）治疗特发性身材矮小儿童至最终身高：剂量效应的证据。
J Pediatr. 2005 Jan;146(1):45-53. doi: 10.1016/j.jpeds.2004.08.055.
2
Height and social adjustment: are extremes a cause for concern and action?身高与社会适应：身高极端情况是否值得关注并采取行动？
Pediatrics. 2004 Sep;114(3):744-50. doi: 10.1542/peds.2003-1169-L.
3
The psychological burden of short stature: evidence against.身材矮小带来的心理负担：反对的证据。
Eur J Endocrinol. 2004 Aug;151 Suppl 1:S29-33. doi: 10.1530/eje.0.151s029.
4
hGH for short stature: ethical issues raised by expanded access.
J Pediatr. 2004 May;144(5):648-52. doi: 10.1016/j.jpeds.2004.02.028.
5
Growth hormone: uses and abuses.生长激素：用途与滥用情况
BMJ. 2004 Apr 17;328(7445):907-8. doi: 10.1136/bmj.328.7445.907.
6
Growth hormone treatment for idiopathic short stature: implications for practice and policy.
Arch Pediatr Adolesc Med. 2004 Feb;158(2):108-10. doi: 10.1001/archpedi.158.2.108.
7
Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment.接受生长激素治疗的儿童和青少年中糖尿病及糖耐量受损的发病率。
Lancet. 2000 Feb 19;355(9204):610-3. doi: 10.1016/S0140-6736(99)04055-6.
8
Growth hormone therapy for the short normal child: who needs it and who wants it? The case against growth hormone therapy.
J Pediatr. 2000 Jan;136(1):103-6. doi: 10.1016/s0022-3476(00)90058-1.
9
Growth hormone use in normal, short children--a plea for reason.在正常矮小儿童中使用生长激素——呼吁理性对待。
N Engl J Med. 1999 Feb 18;340(7):557-9. doi: 10.1056/NEJM199902183400710.
10
Moral assessment of growth hormone therapy for children with idiopathic short stature.特发性身材矮小儿童生长激素治疗的道德评估
J Med Ethics. 1997 Oct;23(5):305-9. doi: 10.1136/jme.23.5.305.
Zotero 插件